Cancer Pain Market Size to Reach USD 8.51 Billion in 2028 With CAGR of 4.3%, Says Reports and Data

Growing awareness of cancer pain as a global clinical problem, increasing focus on developing comprehensive approach to classify cancer pain, and extensive R&D activities to develop advanced non-invasive pain management techniques are some key factors expected to drive market growth

The global cancer pain market size is expected to reach USD 8.51 Billion in 2028 at a CAGR of 4.3% during the forecast period, according to the latest report by Reports and Data. Rapid advancements in neuromodulation technique to treat neuropathic cancer pain, increasing investment to accelerate cancer research, rapidly increasing global burden of cancer pain, and extensive R&D activities to develop effective therapies for better control of cancer pain are key factors expected to drive market revenue growth over the forecast period. In addition, increasing research activities to understand the mechanism of cancer pain and adoption of patient-controlled analgesia are some other key factors expected to contribute to revenue growth over the forecast period.

Cancer pain remains one of the most feared aspects of cancer, and nearly 75% of patients suffering from cancer pain require treatment with opioids to manage severe pain. Pain management in cancer patients is challenging and complex task and remains undertreated globally due to high cancer load, low access to proper resources, and low income in developing countries. Unrelieved cancer pain makes patients uncomfortable and has a massive effect on their daily activities, motivations, social interactions, and overall quality of life. Availability of effective therapies and increasing focus on relieving cancer pain are resulting in advancements in understanding the etiology and pathophysiology of cancer pain. Increasing investment and efforts to develop comprehensive approach to classify cancer pain owing to increasing emphasis on proper management and treatment of cancer pain are also expected to drive market growth over the forecast period.

Access Sample PDF Copy of the Report @

Patients with advanced or metastatic cancer cannot be treated for cancer pain with analgesics and require invasive techniques such as peripheral nerve blockers and neuraxial analgesia for vertebral pain, among others. Increasing advancements in nerve blockers to enhance pain control and offer long-term relief to cancer patients are also expected to drive market revenue growth over the forecast period. However, lack of awareness among clinicians in efficient management of cancer pain, unavailability of opioids in developing countries, and lack of established healthcare infrastructure in low- and middle-income countries are some key factors expected to restrain market growth over the forecast period.

Some Key Highlights from the Report:

  • Opioids segment is expected to account for largest revenue share over the forecast period, owing to rising use of opioids to control and manage cancer pain, availability of opioids at cost-effective prices, and increasing parenteral administration of morphine for better control over cancer pain.
  • Lung cancer segment is expected to register significant revenue growth during 2021-2028 attributed to high prevalence of lung cancer globally, high levels of pain among lung cancer patients, implementation of multidisciplinary approach for pain management, and increasing focus on implementation of optimum pain management strategies to reduce burden of pain and symptoms in lung cancer patients.
  • Parenteral administration offers numerous advantages such as high bioavailability of pain medications, better control over dose and administration rate, and generation of stable pharmacodynamics and pharmacokinetics profiles, and this is expected to boost adoption of parenteral route of administration during cancer pain therapies. In addition, intravenous administration of morphine enables better management of pain in patients with acute cancer pain, for breakthrough pain, and in patients with poor pain control under high opioid dosages, which is expected to further boost revenue growth of the segment going ahead.
  • Asia Pacific is expected to register a steady revenue CAGR over the forecast period, attributable to rising incidence of cancer, rapid advancements in cancer research, development of robust therapeutic pipeline, availability of advanced cancer drugs, and increasing focus on palliative and end-of-life care.
  • Major companies profiled in the market report include Sanofi SA, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Daiichi Sankyo Company, BioDelivery Sciences International, Sorrento Therapeutics Inc., Pfizer Inc., Hisamitsu Pharmaceutical Co. Ltd., Orexo AB, and Insys Therapeutics Inc.

Buy now your Exclusive copy of Report @

For the purpose of this report, Reports and Data has segmented the cancer pain market based on drug type, disease indication, route of administration, and region:

Drug Type Outlook (Revenue, USD Billion; 2018-2028)

  • Opioids
  • NSAIDs
  • Nerve Blockers
  • Others

Disease Indication Outlook (Revenue, USD Billion; 2018-2028)

  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Blood Cancer
  • Prostate Cancer
  • Others

Route of Administration Outlook (Revenue, USD Billion; 2018-2028)

  • Parenteral
  • Oral

Request for Custom Research @

Regional Outlook (Revenue, USD Billion, 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China 
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    •  Rest of MEA

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Medical Stethoscopes Market  by Type (Manual and Mechanical Stethoscopes, Digital Stethoscopes), Application Type (Hospitals, Clinics, Others), and Region- Global Forecast to 2027

Human Growth Hormone Market  Size, Growth & Analysis By Product Type (Powder, Solvent), By Route of Administration (Subcutaneous, Intravenous, Oral, Intramuscular), By Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Idiopathic Short Stature, Others), By Distribution Channel (Hospitals, Online Pharmacies, Retail Pharmacies), By Region, Forecast To 2027

Blood Bags Market  By Type (Single, Double, Triple, Quadruple And Others), By Application Type (Blood Banks, Hospitals And Others), And Region-Global Forecast To 2027

Patient Temperature Management Devices Market  Analysis By Product Type (Patient Warming Systems, Convective Warming Systems, Intravascular Warming Systems, Surface Warming Systems), By Application (Perioperative Care, Acute Care, Newborn Care, Others), By End-User (Surgical Centers, Emergency Care Units, Ambulatory Sites), And By Region, Forecast To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news